CVRx, Inc.(CVRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CVRX CVRx, Inc.

Trading 10-12 09:54:27 EDT

1.60

+0.02

+1.27%

High1.67	Low1.56	Vol30.02K
Open1.58	D1 Closing1.58	Amplitude6.65%
Mkt Cap42.63M	Tradable Cap34.36M	Total Shares26.64M
T/O47.66K	T/O Rate0.14%	Tradable Shares21.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CVRX","market":"US","secType":"STK","nameCN":"CVRx, Inc.","latestPrice":1.6,"timestamp":1791813260536,"preClose":1.58,"halted":0,"volume":30019,"delay":0,"changeRate":0.012658227848101276,"floatShares":21472916,"shares":26641597,"eps":-1.9748,"marketStatus":"Trading","change":0.02,"latestTime":"10-12 09:54:27 EDT","open":1.58,"high":1.665,"low":1.56,"amount":47656.687465200004,"amplitude":0.066456,"askPrice":1.6,"askSize":215,"bidPrice":1.58,"bidSize":905,"shortable":3,"etf":0,"ttmEps":-1.9748,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791835200000},"marketStatusCode":2,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":1.58,"preHourTrading":{"tag":"盘前","latestPrice":1.54,"preClose":1.58,"latestTime":"09:15 EDT","volume":16,"amount":24.64,"timestamp":1791810949816,"change":-0.04,"changeRate":-0.025316,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.58,"preClose":1.58,"latestTime":"17:16 EDT","volume":445,"amount":704.35,"timestamp":1791580570043,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.79899,"impliedVol":0.5014,"impliedVolPercentile":0.1673},"requestUrl":"/m/hq/s/CVRX/wiki","defaultTab":"wiki","newsList":[{"id":"2671386247","title":"CVRx to Present Late-Breaking Rebalance Registry Real-World Barostim Outcomes at HFSA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671386247","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671386247?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:30","pubTimestamp":1790713855,"startTime":"0","endTime":"0","summary":"CVRx to present late-breaking REBALANCE Registry real-world Barostim outcomes at HFSA 2026CVRx flagged new clinical evidence for its Barostim heart-failure device ahead of the HFSA Annual Scientific M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL2ZPX16:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","BK4539","CVRX","IE00BKPKM429.USD","IE00BQXX3F31.USD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","BK4588","SG9999014005.SGD","BCDF","LU2210149790.SGD","LU2210150020.SGD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669473129","title":"Wall Street Analysts Are Neutral on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669473129","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669473129?lang=en_us&edition=fundamental","pubTime":"2026-09-23 01:40","pubTimestamp":1790098815,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Merck & Company (MRK) and CVRx (CVRX) with neutral ratings, indicating that the experts are neither b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-neutral-on-top-healthcare-picks-blurbs-news-17?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-neutral-on-top-healthcare-picks-blurbs-news-17?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRK","BK4516","LU1116320901.HKD","BK4585","LU1037948897.HKD","LU0265550946.USD","LU2357627491.SGD","LU2361045086.USD","LU1934455863.HKD","BK4588","LU0320765646.SGD","LU0432979614.USD","LU0965508806.USD","PPH","LU0266013472.USD","LU1983299246.USD","LU1061106388.HKD","LU1066051811.HKD","LU2089984988.USD","IE00BLSP4452.SGD","LU0823416689.USD","LU0965509010.AUD","LU2112291526.USD","LU1057294990.SGD","BMED","LU0265550359.USD","FHLC","SG9999014567.USD","TRUH","LU0057025933.USD","LU0289739699.SGD","LU0477156953.USD","LU1941712264.USD","IYH","LU0868494617.USD","BK4539","LU2106854487.HKD","SG9999013999.USD","FTXH","LU0942090050.USD","LU1923622614.USD","LU0289961442.SGD","BK4559","LU1917777945.USD","LU2360032135.SGD","LU1032466523.USD","LU1699723380.USD","LU2125154778.USD","SG9999015341.SGD","JDOC","LU1201861249.SGD","LU1093756325.SGD","LU0234572021.USD","IE00BBT3K403.USD","LU2361044865.SGD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1066051225.USD","LU2491049909.HKD","LU0472753341.HKD","LU2433249047.HKD","RXL","LU1093756168.USD","IE00BLSP4239.USD","LU0985320562.USD","SGXZ57979304.SGD","LU0069063385.USD","LU1066053197.SGD","IE0009355771.USD","LU2491050071.SGD","GDOC","BK4550","LU1989771016.USD","LU1430594728.SGD","LU2125909247.SGD","LU2023250843.SGD","LU0006306889.USD","IE00BSNM7G36.USD","LU1571399168.USD","IE000M9KFDE8.USD","SG9999001176.SGD","LU0868494708.USD","LU1162221912.USD","LU2461242641.AUD","LU1989772923.USD","BK4534","LU1023059063.AUD","LU0511384066.AUD","LU0965509101.SGD","LU1989772840.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","SG9999002232.USD","SG9999014542.SGD","LU2468319806.SGD","PAWZ","SG9999014575.USD","LU1934455194.USD","LU2125909593.SGD","IXJ","IE00BFTCPJ56.SGD","LU1941712348.USD","LU1934455277.USD","LU0098860793.USD","LU1066051498.USD","SG9999015358.SGD","LU2324357040.USD","LU0106261372.USD","LU2125154935.USD","BK4533","LU0203347892.USD","LU0980610538.SGD","SG9999001176.USD","IHE","LU0058720904.USD","LU0124676726.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0859254822.USD","LU0861579265.USD","VHT","CVRX","LU0320765489.SGD","SG9999014559.SGD","LU1037948541.HKD","BK4007","LU0072461881.USD","LU0211331839.USD","LU1291159041.SGD","SG9999001440.SGD","SG9999002224.SGD","LU0689626769.HKD","LU0130102774.USD","LU0122379950.USD","LU0648001328.SGD","LU0130517989.USD","LU1974910355.USD","LU0070302665.USD","LU0238689110.USD","LU0289739343.SGD","LU1929549753.HKD","BK4082","HRTS","IE0002141913.USD","LU0162691827.USD","LU0203345920.USD","LU1069347547.HKD","LU1035773651.USD","LU2023250504.SGD","LU1585245621.USD","LU2491050154.USD","LU2361044949.HKD","LU1116320737.USD","IE00BN8TJ469.HKD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149323","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (VRDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149323?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:10","pubTimestamp":1790075417,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cvrx-cvrx-butterfly-network-bfly-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cvrx-cvrx-butterfly-network-bfly-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","VRDN","LU0128526141.USD","CVRX","BK4137","BK4581","XLV","BK4585","BK4539","BFLY","BK4139","BK4082","HCSG","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669931541","title":"CVRx appoints veteran medtech executive as new CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669931541","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669931541?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:54","pubTimestamp":1790024085,"startTime":"0","endTime":"0","summary":"CVRx ( ($CVRX) ) just unveiled an announcement. On September 21, 2026, CVRx announced that its board has appointed veteran medtech finance executiv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cvrx-appoints-veteran-medtech-executive-as-new-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cvrx-appoints-veteran-medtech-executive-as-new-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669886193","title":"Nyxoah Names Loic Moreau Interim CFO as John Landry Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2669886193","media":"MT Newswires Live","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669886193?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:33","pubTimestamp":1790022787,"startTime":"0","endTime":"0","summary":"Nyxoah  has named Loic Moreau as interim chief financial officer, effective Oct. 2, succeeding John Landry, who is stepping down, the company said late Monday.Moreau is the company's president international and a former CFO.Nyxoah reaffirmed its full-year 2026 worldwide net revenue guidance of 36 million euros  to 40 million euros.CVRx  said late Monday it has appointed John Landry as CFO, starting Oct. 12.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NYXH","BK4082","CVRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669198756","title":"CVRx Names New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669198756","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669198756?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:23","pubTimestamp":1790022211,"startTime":"0","endTime":"0","summary":"CVRx (CVRX) said late Monday it has appointed John Landry as chief financial officer, starting Oct. 12.Landry, currently serving as CFO of Nyxoah (NYXH), succeeds Jared Oasheim, who will remain with CVRx for a transition period, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4082","NYXH","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669198216","title":"CVRx appoints John Landry as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669198216","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669198216?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:15","pubTimestamp":1790021707,"startTime":"0","endTime":"0","summary":"CVRx (CVRX) announced that John Landry has been appointed CFO, succeeding Jared Oasheim, whose resignation was previously announced. Landry will jo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cvrx-appoints-john-landry-as-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cvrx-appoints-john-landry-as-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVRX","BK4539","BK4082","CFO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669198189","title":"CVRx Names Nyxoah CFO John Landry as Finance Chief","url":"https://stock-news.laohu8.com/highlight/detail?id=2669198189","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669198189?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:07","pubTimestamp":1790021258,"startTime":"0","endTime":"0","summary":"CVRx names Nyxoah CFO John Landry as finance chiefCVRx named John Landry chief financial officer, replacing Jared Oasheim, whose resignation had been disclosed.Landry joins Oct. 12, 2026. He takes ove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL36qflv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014005.SGD","BCDF","BK4082","IE00BN0W2W23.USD","IE00BQXX3F31.USD","BK4588","BK4112","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","BK4585","LU2095319765.USD","CVRX","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4539","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669989021","title":"CVRx Appoints John Landry as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669989021","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669989021?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:07","pubTimestamp":1790021241,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA8BKHXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669900198","title":"CVRx, - John Landry to Join CVRx on Oct 12, 2026 and Assume CFO Role After Q3 10-Q Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669900198","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669900198?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:07","pubTimestamp":1790021241,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA8BKHXQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CVRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666157573","title":"CVRx’s BAROSTIM Registry: Real‑World Hypertension Data That Could Move the Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2666157573","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666157573?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:31","pubTimestamp":1789144280,"startTime":"0","endTime":"0","summary":"Cvrx, Inc. ($CVRX) announced an update on their ongoing clinical study. The BAROSTIM THERAPY™ in Resistant Hypertension registry, officially titled...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cvrxs-barostim-registry-realworld-hypertension-data-that-could-move-the-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cvrxs-barostim-registry-realworld-hypertension-data-that-could-move-the-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666575763","title":"BAROSTIM NEO Trial Update: Long-Term Hypertension Data in Focus for CVRX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666575763","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666575763?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:30","pubTimestamp":1789144246,"startTime":"0","endTime":"0","summary":"Cvrx, Inc. ($CVRX) announced an update on their ongoing clinical study. The BAROSTIM NEO Hypertension Pivotal Trial extension is designed to track ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/barostim-neo-trial-update-long-term-hypertension-data-in-focus-for-cvrx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/barostim-neo-trial-update-long-term-hypertension-data-in-focus-for-cvrx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4211","ISBC","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734358","title":"CVRx Says Board Reviews Options After Pointillist Letter, Sees Barostim Undervalued","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734358","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734358?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:04","pubTimestamp":1787659489,"startTime":"0","endTime":"0","summary":"CVRx says board reviews options after Pointillist letter, sees Barostim undervaluedCVRx responded to a Pointillist Family Office letter dated Aug. 24, 2026, citing ongoing evaluation of value-maximizi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL7lQqDJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD","BK4082","SG9999014013.SGD","LU0314104364.USD","BK4539","BK4112","IE00BN0W2V16.EUR","NDAQ","BK4588","CVRX","SG9999014005.SGD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","IE00B64PRP62.GBP","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731774","title":"CVRx, Inc.: Board is Open to Constructive Engagement with All of Its Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662731774?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0A0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CVRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662310887","title":"CVRx, - Board Regularly Evaluates Options to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2662310887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662310887?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44M0A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732691","title":"CVRx Responds to Letter from Pointillist Family Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732691","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732691?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659200,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Aug.  25, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (\"CVRx\"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neurom","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350401/0/en/cvrx-responds-to-letter-from-pointillist-family-office.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CVRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276025","title":"CVRx Shareholder Chernett Urges Board to Start Immediate Sale Process to Strategic Buyer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276025","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276025?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:32","pubTimestamp":1787574727,"startTime":"0","endTime":"0","summary":"CVRx shareholder Chernett urges board to start immediate sale process to strategic buyerPointillist Family Office founder Jorey Chernett, holding more than 5.5% of CVRx shares, urged the board to star","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL85xzBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727679","title":"Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727679?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574615,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L06M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276037","title":"Jorey Chernett: Calls on CVRx Board Initiate a Comprehensive Review of Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276037","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276037?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574615,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L06M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276799","title":"CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276799?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA9ZG5KY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4082","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cvrx.com","stockEarnings":[{"period":"1week","weight":0.0194},{"period":"1month","weight":-0.4417},{"period":"3month","weight":-0.709},{"period":"6month","weight":-0.7792},{"period":"1year","weight":-0.8275},{"period":"ytd","weight":-0.7775}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.0313},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1417}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.093597},{"month":2,"riseRate":0.4,"avgChangeRate":-0.085377},{"month":3,"riseRate":0.2,"avgChangeRate":-0.089798},{"month":4,"riseRate":0.4,"avgChangeRate":-0.093376},{"month":5,"riseRate":0.2,"avgChangeRate":-0.166016},{"month":6,"riseRate":0.4,"avgChangeRate":0.146711},{"month":7,"riseRate":0.666667,"avgChangeRate":0.068189},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.089059},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.076369},{"month":10,"riseRate":0.666667,"avgChangeRate":0.106589},{"month":11,"riseRate":0.6,"avgChangeRate":0.134494},{"month":12,"riseRate":0.6,"avgChangeRate":0.102852}],"exchange":"NASDAQ","name":"CVRx, Inc.","nameEN":"CVRx, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CVRx, Inc.(CVRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CVRx, Inc.(CVRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CVRx, Inc.,CVRX,CVRx, Inc.股票,CVRx, Inc.股票老虎,CVRx, Inc.股票老虎国际,CVRx, Inc.行情,CVRx, Inc.股票行情,CVRx, Inc.股价,CVRx, Inc.股市,CVRx, Inc.股票价格,CVRx, Inc.股票交易,CVRx, Inc.股票购买,CVRx, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CVRx, Inc.(CVRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CVRx, Inc.(CVRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction